TAIHO PHARMA

We strive to
improve human
health and contribute
to a society enriched
by smiles

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Release

September 20, 2017

Taiho Pharmaceutical Concludes Option and License Agreement with Arcus Biosciences
September 07, 2017

Taiho Pharmaceutical Releases Harncare Granules Nationwide in Japan on Thursday, September 7ーan Effective Herbal Remedy to Improve Urinary Function by Warming up the Body from the Inside.
August 25, 2017

Antitumor Agent Abraxane_® I.V. Infusion 100 mg Approved for Additional Dosage and Administration for Gastric Cancer
June 02, 2017

Taiho Pharmaceutical to Construct Facility for Production of Highly Potent Pharmaceutical Ingredients
May 18, 2017

Taiho Pharmaceutical Receives Approval for the Additional Indications of Complicated Skin and Soft Tissue Infections for ZOSYN_®, an Injectable Antibiotic Combined with β-lactamase Inhibitor